A Broad-Spectrum Inhibitor of CRISPR-Cas9
Lucas B. Harrington(Mammoth Biosciences (United States)), Jennifer A. Doudna(University of California, Berkeley), Nadia Amrani(Unknown), Kevin Doxzen(University of California, Berkeley), Janice S. Chen(Mammoth Biosciences (United States)), Erik J. Sontheimer(University of Massachusetts Chan Medical School), Alireza Edraki(University of Massachusetts Chan Medical School), Karen L. Maxwell(University of Toronto), Alan R. Davidson(University of Toronto), Joshua C. Cofsky(University of California, Berkeley), Philip J. Kranzusch(Harvard University), Junjie Liu(King Center), Enbo Ma(Innovative Genomics Institute), Bianca Garcı́a(University of Toronto), Gavin J. Knott(Discovery Institute)
Cited by 270
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
CRISPR–Cas12-based detection of SARS-CoV-2
|Nature Biotechnology|2020|2.8k
RNA-programmed genome editing in human cells
|eLife|2013|2.1k
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
|Nature|2014|1.9k